Buscar
-
Of glue and pot: Endocannabinoid signaling in glial cells
(Glia. vol. 71, n° 1, pp. 3-4, 2023-01-01)Article de revue -
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
(CNS drugs. vol. 35, n° 11, pp. 1217-1232, 2021-11)Article de revue -
Visualization of the saccule and utricle with non-contrast-enhanced FLAIR sequences
(European Radiology. vol. 32, n° 5, pp. 3532-3540, 2022-05)Article de revue -
Astroglial CB1 receptors, energy metabolism, and gliotransmission: an integrated signaling system?
(Essays in Biochemistry. vol. 67, n° 1, pp. 49-61, 2023-03-03)Article de revue -
Young researchers series #6
(Trends in Cell Biology. vol. 33, n° 2, pp. 87-91, 2023-02)Article de revue -
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
(Drugs, 2023-12-21)Article de revue -
Endocannabinoid-related molecules predict the metabolic efficacy of GLP-1 receptor agonism in humans with obesity
(Journal of Endocrinological Investigation, 2023-11-04)Article de revue -
Longitudinal investigation of patients receiving involuntary treatment for extremely severe anorexia nervosa
(European Eating Disorders Review, 2023-09-10)Article de revue -
Microstructural Gray Matter Integrity Deteriorates After an Ischemic Stroke and Is Associated with Processing Speed
(Translational stroke research. vol. 14, n° 2, pp. 185-192, 2023-04-14)Article de revue -
Discovery of a new type of neuroimmune interaction in the aged brain's response to energy surfeit
(Brain, Behavior, and Immunity. vol. 110, pp. 288-289, 2023-05)Article de revue